|     							  							  								|  |    								|   |    								|   |    								| On May 3 in Boston, we're bringing together a diverse group of perspectives to share their journeys across the drug development process, and ultimate tales of success. Secure your event ticket here. |    								|  |    								| By Bob Herman Mike Reddy for STAT A surgeon who relies on out-of-network billing is trying to get the entire surprise billing law thrown out. Read More |    								| By Megan Molteni Patrick Semansky/AP While age remains a strong risk factor with Covid, vaccines and treatments have greatly decreased the threat of grave illness, experts said. Read More |    								| By Patrick Skerrett The new number has been in the works for several years, but only a handful of states have supported it structurally and financially. Read More |    					| Sponsor content by Abbott The future of heart failure tech: Cutting-edge innovation for the full continuum of careA new era in heart failure innovation has begun. However, hurdles remain as tens of thousands of patients are still without the treatment they need. Heart failure remains a complex disease — requiring innovative solutions and connected care. Discover how Abbott continues to fight heart failure using state-of-the-art technology while using data-driven insights. |    								| By Tara Bannow Rich Pedroncelli/AP The long-running federal antitrust lawsuit against Sutter Health is getting a second wind after attorneys filed a notice of appeal Tuesday.  Read More |    								| By Jesse Gubb Adobe Randomized tests enable rigorous evaluation of tests of Medicare and Medicare innovations. Making them voluntary muddies the water. Read More |    								  							 | 
  			
  		
No comments